Pharmaceutical - Pharmaceutical, Vaccines

Filter

Current filters:

PharmaceuticalVaccines

Popular Filters

1 to 25 of 213 results

Positive WHO assessment of China’s vaccines regulatory authority

Positive WHO assessment of China’s vaccines regulatory authority

06-07-2014

China's national vaccine supervision system has met or passed all the standard requirements of the World…

ChinaPharmaceuticalRegulationVaccines

Japan marketing approval for Canaglu; vaccine license for Daiichi Sankyo

Japan marketing approval for Canaglu; vaccine license for Daiichi Sankyo

04-07-2014

Japanese drug major Mitsubishi Tanabe Pharma has received approval to manufacture and market the SGLT2…

canagliflozinCanagluDaiichi SankyoDiabetesJapanMitsubishi TanabePharmaceuticalRegulationSanofi PasteurVaccines

CureVac in deal with Sanofi Pasteur for mRNA-based prophylactic vaccine

01-07-2014

German clinical-stage biopharma company CureVac has entered into an exclusive license agreement with…

LicensingPharmaceuticalSanofiSanofi PasteurVaccines

FDA licenses Novartis facility to produce cell-culture influenza vaccines

FDA licenses Novartis facility to produce cell-culture influenza vaccines

16-06-2014

The US Food and Drug Administration has licensed Swiss pharma major Novartis’ manufacturing facility…

FlucelvaxNovartisPharmaceuticalProductionRegulationUSAVaccines

PaxVax signs R&D deal with UC San Diego to develop herpes vaccine

PaxVax signs R&D deal with UC San Diego to develop herpes vaccine

11-06-2014

Privately-held California, USA-based specialty vaccine firm PaxVax has entered into a research and development…

Anti-viralsLicensingPaxVaxPharmaceuticalResearchVaccines

Changes to the funding access criteria for some vaccines in New Zealand

Changes to the funding access criteria for some vaccines in New Zealand

09-06-2014

New Zealand’s Pharmaceutical Management Agency, PHARMAC, this morning announced changes to the funding…

FinancialHealthcareNew ZealandPharmaceuticalVaccines

Global vaccines producers could lose $300 million state contracts in Russia to local firm

Global vaccines producers could lose $300 million state contracts in Russia to local firm

29-05-2014

The world’s leading producers of vaccines may lose access to the Russian market, amid the pressure…

PharmaceuticalProductionRussiaVaccines

GSK commits to five-year vaccine price freeze for countries graduating from GAVI Alliance support

22-05-2014

UK pharma giant GlaxoSmithKline has said it will freeze the prices of its vaccines for a period of five…

GlaxoSmithKlineGlobalPharmaceuticalPricingVaccines

$150 million new vaccines plant commissioned in Russia

08-05-2014

Russia’s largest plant for the production of vaccines and one of the biggest in Eastern Europe was…

Fort GroupPharmaceuticalProductionRussiaVaccines

EU health ministers agree on joint vaccination procurements

30-04-2014

European Union health ministers, during an informal meeting in Athens, Greece, laid the groundwork for…

EuropeHealthcarePharmaceuticalVaccines

Novartis Vaccines appoints new Medical Affairs Director for North Europe

Novartis Vaccines appoints new Medical Affairs Director for North Europe

25-04-2014

Novartis Vaccines, the vaccination branch of Swiss drug major Novartis (NOVN: VX), has announced the…

BiotechnologyBoardroomNovartisPharmaceuticalUKVaccines

Novartis swaps products with GlaxoSmithKline, sells unit to Lilly

Novartis swaps products with GlaxoSmithKline, sells unit to Lilly

22-04-2014

In what looks like a significant restructuring of company focuses, Swiss drug major Novartis and UK peer…

Eli LillyGlaxoSmithKlineMergers & AcquisitionsNovartisPharmaceuticalVaccines

Joint purchasing of vaccines and medicines becomes a reality in the EU

Joint purchasing of vaccines and medicines becomes a reality in the EU

10-04-2014

The European Commission today approved a Joint Procurement Agreement, which will enable all European…

Antibiotics and Infectious diseasesEuropeFinancialMarkets & MarketingPharmaceuticalVaccines

UK about turn, as JCVI now recommends meningitis B vaccination for infants

21-03-2014

The UK’s Joint Committee on Vaccination and Immunization has recommended that the meningitis B vaccine…

BexseroNorthern EuropeNovartisPharmaceuticalRegulationUKVaccines

Pfizer’s vaccine candidate bivalent rLP2086 gains “Breakthrough” status

Pfizer’s vaccine candidate bivalent rLP2086 gains “Breakthrough” status

20-03-2014

The US Food and Drug Administration has granted Breakthrough Therapy designation to pharma behemoth Pfizer’s…

North AmericaPfizerPharmaceuticalRegulationrLP2086USAVaccines

Sanofi Pasteur inks deal with Korea’s SK Chemical on vaccines

Sanofi Pasteur inks deal with Korea’s SK Chemical on vaccines

19-03-2014

In a second collaboration in less than a month, Sanofi Pasteur, the vaccines division of French drug…

Asia-PacificLicensingPharmaceuticalResearchSanofiSanofi PasteurSK ChemicalVaccines

Pharma Summit: Merck’s European president Bruno Strigini highlights importance of innovation

Pharma Summit: Merck’s European president Bruno Strigini highlights importance of innovation

17-03-2014

The president of pharma giant Merck & Co’s (NYSE: MRK) operations in Europe and Canada Bruno Strigini…

Anti-viralsCanadaDiabetesEuropeInterviewsMerck & CoMK-3475OncologyPharmaceuticalRegulationUKVaccines

Daiichi Sankyo unit will not hit H5N1 vaccine supply deadline

Daiichi Sankyo unit will not hit H5N1 vaccine supply deadline

10-03-2014

Japanese drug major Daiichi Sankyo has updated on the H5N1 influenza vaccine project, revealing that…

Asia-PacificDaiichi SankyoJapanPharmaceuticalProductionVaccines

UK strengthens biopharma ties with India

UK strengthens biopharma ties with India

10-03-2014

The UK's Permanent Secretary of Department of Health Una O’Brien recently led a health care mission…

HealthcareIndiaPharmaceuticalUKVaccines

Sanofi Pasteur wins order for IPV from UNICEF, cutting price to $1 per dose

28-02-2014

Sanofi Pasteur, the vaccines division of French drug major Sanofi, says that UNICEF, the organization…

GlobalMarkets & MarketingPharmaceuticalPricingSanofiSanofi PasteurVaccines

Positive top-line results for Pfizer’s Prevenar 13 in pneumonia in over 65s

25-02-2014

US pharma behemoth Pfizer says that top-line results from a study of Prevenar 13 (pneumococcal 13-valent…

Antibiotics and Infectious diseasesPfizerPharmaceuticalPrevenarResearchVaccines

Daiichi Sankyo and UMN Pharma collaborate over norovirus vaccine

Daiichi Sankyo and UMN Pharma collaborate over norovirus vaccine

14-02-2014

Japanese drug companies Daiichi Sankyo and UMN Pharma have signed a collaborative research agreement…

Daiichi SankyoJapanLicensingPharmaceuticalResearchVaccines

Cost is preventing boys receiving anti-cancer vaccine for HPV

Cost is preventing boys receiving anti-cancer vaccine for HPV

13-02-2014

While national health systems have been pushing to increase the human papillomavirus (HPV) vaccine uptake…

CervarixEuropeGardasilGlaxoSmithKlineHealthcareMerck & CoPharmaceuticalUSAVaccines

Australia’s CSL posts solid half-year results

Australia’s CSL posts solid half-year results

13-02-2014

Australian blood products and vaccine maker CSL reported a 3% rise in net profit to $646 million (all…

CSL LimitedFinancialHematologyPharmaceuticalVaccines

1 to 25 of 213 results

Back to top